Edesa Biotech, Inc. (EDSA)

NASDAQ: EDSA · Real-Time Price · USD

5.43

+0.13 (2.45%)

At close: Aug 13, 2026, 4:00 PM EDT

5.61

+0.18 (3.31%)

After-hours: Aug 13, 2026, 7:38 PM EDT

Edesa Biotech Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Cost of Revenue	0	-	-	-	-	-
Gross Profit	-0	-	-	-	-	-
Selling, General & Admin	5.02	4.24	4.13	4.43	5.04	5.73
Research & Development	8.48	3.67	2.88	4.79	13.34	17.95
Total Operating Expenses	13.5	7.91	7.01	9.22	18.37	23.68
Operating Income	-13.39	-7.91	-7.01	-9.22	-18.37	-23.68
Total Non-Operating Income (Expense)	0.45	0.73	0.85	0.85	0.82	10.34
Pretax Income	0	-7.18	-6.17	-8.37	-17.55	-13.34
Provision for Income Taxes	0	0	0	0	0	0
Net Income	-	-7.19	-6.17	-8.37	-17.55	-13.34
Net Income to Common	-12.95	-7.19	-6.17	-8.37	-17.55	-13.34
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	8	6	3	3	2	2
Shares Outstanding (Diluted)	8	6	3	3	2	2
Shares Change	72.17%	77.54%	3.96%	33.61%	32.28%	41.52%
EPS (Basic)	-1.69	-1.27	-1.93	-2.72	-5.46	-7.07
EPS (Diluted)	-1.69	-1.27	-1.93	-2.72	-5.46	-7.07
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Free Cash Flow	-9.7	-7.32	-4.89	-6.64	-12.28	-13.67
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-1.19	-1.29	-1.53	-2.16	-5.34	-7.86
EBITDA	-13.29	-7.79	-6.83	-9.04	-18.25	-23.56
EBIT	-13.39	-7.91	-7.01	-9.22	-18.37	-23.68
Effective Tax Rate	100.00%	-0.01%	-0.01%	-0.01%	-0.00%	-0.01%

SEC Filings: 10-K · 10-Q